PL3302704T3 - Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) do zmniejszania masy tłuszczowej - Google Patents

Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) do zmniejszania masy tłuszczowej

Info

Publication number
PL3302704T3
PL3302704T3 PL16804333.9T PL16804333T PL3302704T3 PL 3302704 T3 PL3302704 T3 PL 3302704T3 PL 16804333 T PL16804333 T PL 16804333T PL 3302704 T3 PL3302704 T3 PL 3302704T3
Authority
PL
Poland
Prior art keywords
beta
hmb
methylbutyrate
hydroxy
compositions
Prior art date
Application number
PL16804333.9T
Other languages
English (en)
Inventor
John Rathmacher
Naji Abumrad
Shawn Baier
Original Assignee
Metabolic Technologies, LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Technologies, LLC filed Critical Metabolic Technologies, LLC
Publication of PL3302704T3 publication Critical patent/PL3302704T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16804333.9T 2015-06-01 2016-06-01 Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) do zmniejszania masy tłuszczowej PL3302704T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562169334P 2015-06-01 2015-06-01
PCT/US2016/035273 WO2016196637A1 (en) 2015-06-01 2016-06-01 Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (hmb) for decreasing fat mass

Publications (1)

Publication Number Publication Date
PL3302704T3 true PL3302704T3 (pl) 2023-05-22

Family

ID=57397749

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16804333.9T PL3302704T3 (pl) 2015-06-01 2016-06-01 Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) do zmniejszania masy tłuszczowej

Country Status (15)

Country Link
US (4) US20160346238A1 (pl)
EP (1) EP3302704B1 (pl)
JP (1) JP6858714B2 (pl)
CN (2) CN117257783A (pl)
AU (2) AU2016271395A1 (pl)
CA (1) CA2987934A1 (pl)
DK (1) DK3302704T3 (pl)
ES (1) ES2937282T3 (pl)
FI (1) FI3302704T3 (pl)
HK (1) HK1252405A1 (pl)
HU (1) HUE061747T2 (pl)
MX (1) MX2017015418A (pl)
PL (1) PL3302704T3 (pl)
PT (1) PT3302704T (pl)
WO (1) WO2016196637A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11406609B2 (en) 2016-01-21 2022-08-09 Metabolic Technologies, Inc. Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy
WO2017127675A1 (en) * 2016-01-21 2017-07-27 Metabolic Technololgies, Inc. COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) FOR MODULATING AUTOPHAGY AND LIPOPHAGY
JP7104636B2 (ja) 2016-06-27 2022-07-21 ザ ジェネラル ホスピタル コーポレーション ドゥーイング ビジネス アズ マサチューセッツ ジェネラル ホスピタル ミトコンドリア生物の活性化による血小板産生刺激
JP2021509686A (ja) * 2018-01-05 2021-04-01 テキサス・テック・ユニバーシティー・オフィス・オブ・リサーチ・コマーシャライゼーション 間欠性絶食に関連するβ−ヒドロキシ−β−メチルブチレート（ＨＭＢ）の組成物およびその使用法
JP7202800B2 (ja) * 2018-07-13 2023-01-12 ライオン株式会社 水分散性組成物、食品組成物、水分散液及び泡立ち抑制方法
WO2022035245A1 (ko) * 2020-08-14 2022-02-17 서울대학교병원 초저열량 및 고생체흡수율 단백질 식품 조성물 및 이를 이용한 식이 요법 정보 제공 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087472A (en) * 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US5028440A (en) 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20080161929A1 (en) 2006-12-29 2008-07-03 Mccormack Bruce Cervical distraction device
WO2009066303A2 (en) * 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
WO2010068696A1 (en) * 2008-12-09 2010-06-17 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
EP2512236B1 (en) * 2009-12-18 2016-10-19 Metabolic Technologies, Inc. Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb)
RU2631597C2 (ru) * 2011-07-15 2017-09-25 Нусерт Сайенсиз, Инк. Композиции и способы модулирования метаболических путей
SG10201709195TA (en) * 2012-11-13 2017-12-28 Nusirt Sciences Inc Compositions and methods for increasing energy metabolism
CA2923705C (en) * 2013-10-09 2024-05-14 Nestec S.A. Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
WO2015105981A2 (en) * 2014-01-09 2015-07-16 Abbott Laboratories Conditional essentiality of hmb

Also Published As

Publication number Publication date
US20250057792A1 (en) 2025-02-20
HK1252405A1 (zh) 2019-05-24
US20180098951A1 (en) 2018-04-12
JP2018516934A (ja) 2018-06-28
AU2019203595B2 (en) 2020-11-19
AU2016271395A1 (en) 2017-12-21
EP3302704B1 (en) 2023-01-25
CA2987934A1 (en) 2016-12-08
BR112017025788A2 (pt) 2018-08-07
ES2937282T3 (es) 2023-03-27
CN107847759A (zh) 2018-03-27
PT3302704T (pt) 2023-02-13
EP3302704A1 (en) 2018-04-11
US20160346238A1 (en) 2016-12-01
AU2019203595A1 (en) 2019-06-13
JP6858714B2 (ja) 2021-04-14
DK3302704T3 (da) 2023-02-13
MX2017015418A (es) 2018-08-24
EP3302704A4 (en) 2019-03-06
US20200405668A1 (en) 2020-12-31
WO2016196637A1 (en) 2016-12-08
CN117257783A (zh) 2023-12-22
FI3302704T3 (fi) 2023-02-28
US10772856B2 (en) 2020-09-15
HUE061747T2 (hu) 2023-08-28

Similar Documents

Publication Publication Date Title
IL274276A (en) CASZ preparations and methods of use
GB2582100B (en) CAS12C Compositions and methods of use
IL260257A (en) Preparations and methods for the treatment of hemoglobinopathies
ZA201801511B (en) Flavonoid compositions and methods of use
ZA201906169B (en) Synthekine compositions and methods of use
HUE068774T2 (hu) Magas elaszticitású hialuronán készítmények és azok alkalmazásai
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
SG10202004071UA (en) Cryoprecipitate compositions and methods of preparation thereof
IL275739A (en) Preparations for cryopreservation and methods of their use
PT3288379T (pt) Composições de péptido e métodos de utilização
ES3063931T3 (en) Compositions containing thymohydroquinone and their method of preparation
PT3302704T (pt) Composições e métodos de utilização de beta-hidroxi-beta-metilbutirato (hmb) para diminuir a massa gorda
IL257458A (en) dpep-1 binding compositions and methods of use
ZA201800175B (en) Methods and compositions for selective regulation of protein expression
SG11201803284YA (en) Novel method of use and compositions
GB201801566D0 (en) Methods and compositions for nanormulsion vaccine formulations
ZA201802376B (en) Compositions and methods for treatment of homocystinuria
HUE044559T2 (hu) Lerakódást gátló készítmények és alkalmazási eljárásaik
IL261794A (en) Preparations and methods for using them
IL247645A0 (en) Preparations of seleno-organic compounds and methods of using them
SG11201706369PA (en) Compositions and methods for the treatment of mucositis
PT3528801T (pt) Composições e métodos de utilização de beta-hidroxi-beta-metilbutirato (hmb) e probióticos
GB201521083D0 (en) Compositions for treatment and methods thereof
GB201408738D0 (en) Components and methods for formulation of components